NDC 53217-284

Gabapentin

Gabapentin

Gabapentin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Aidarex Pharmaceuticals Llc. The primary component is Gabapentin.

Product ID53217-284_041af629-e2da-4269-b675-7766fc40b51d
NDC53217-284
Product TypeHuman Prescription Drug
Proprietary NameGabapentin
Generic NameGabapentin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2011-01-29
Marketing CategoryANDA / ANDA
Application NumberANDA090858
Labeler NameAidarex Pharmaceuticals LLC
Substance NameGABAPENTIN
Active Ingredient Strength300 mg/1
Pharm ClassesAnti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 53217-284-22

270 CAPSULE in 1 BOTTLE (53217-284-22)
Marketing Start Date2011-01-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 53217-284-81 [53217028481]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-01-29
Inactivation Date2020-01-31

NDC 53217-284-02 [53217028402]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-01-29
Inactivation Date2020-01-31

NDC 53217-284-30 [53217028430]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-01-29
Inactivation Date2020-01-31

NDC 53217-284-00 [53217028400]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-01-29
Inactivation Date2020-01-31

NDC 53217-284-42 [53217028442]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-01-29
Inactivation Date2020-01-31

NDC 53217-284-21 [53217028421]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-01-29
Inactivation Date2020-01-31

NDC 53217-284-90 [53217028490]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-01-29
Inactivation Date2020-01-31

NDC 53217-284-22 [53217028422]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-01-29
Inactivation Date2020-01-31

NDC 53217-284-99 [53217028499]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-01-29
Inactivation Date2020-01-31

NDC 53217-284-15 [53217028415]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-01-29
Inactivation Date2020-01-31

NDC 53217-284-45 [53217028445]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-01-29
Inactivation Date2020-01-31

NDC 53217-284-60 [53217028460]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-01-29
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
GABAPENTIN300 mg/1

OpenFDA Data

SPL SET ID:633e0bbe-579d-40c6-9347-d357291708e0
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 310431

    • Pharmacological Class

    • Anti-epileptic Agent [EPC]
    • Decreased Central Nervous System Disorganized Electrical Activity [PE]

    NDC Crossover Matching brand name "Gabapentin" or generic name "Gabapentin"

    NDCBrand NameGeneric Name
    0093-4443GabapentinGabapentin
    0093-4444GabapentinGabapentin
    0143-3991GabapentinGabapentin
    0143-3993GabapentinGabapentin
    0143-3994GabapentinGabapentin
    0143-9992GabapentinGabapentin
    0143-9993GabapentinGabapentin
    0143-9994GabapentinGabapentin
    67877-222GabapentinGabapentin
    67877-223GabapentinGabapentin
    67877-224GabapentinGabapentin
    67877-428GabapentinGabapentin
    67877-429GabapentinGabapentin
    68001-006GabapentinGabapentin
    68001-007GabapentinGabapentin
    68071-1212GABAPENTINGABAPENTIN
    68071-1292GabapentinGabapentin
    68071-1808GABAPENTINGABAPENTIN
    68071-1907GABAPENTINGABAPENTIN
    68071-1995GabapentinGabapentin
    68071-3230GABAPENTINGABAPENTIN
    68071-3046GabapentinGabapentin
    68071-3244GabapentinGabapentin
    68071-4087GabapentinGabapentin
    68071-3086GABAPENTINGABAPENTIN
    68071-3383GABAPENTINGABAPENTIN
    68071-3314GABAPENTINGABAPENTIN
    68071-4049GABAPENTINGABAPENTIN
    68071-4241GABAPENTINGABAPENTIN
    68071-4099GabapentinGabapentin
    68071-4113GabapentinGabapentin
    68071-4292GabapentinGabapentin
    68071-4180GabapentinGabapentin
    68071-4090GabapentinGabapentin
    68071-4329GabapentinGabapentin
    68071-4603GabapentinGabapentin
    68071-4169GabapentinGabapentin
    68071-4346GabapentinGabapentin
    68071-4366GabapentinGabapentin
    68071-4729GabapentinGabapentin
    68071-4402GABAPENTINGABAPENTIN
    68071-4784GABAPENTINGABAPENTIN
    68084-774GabapentinGabapentin
    68084-783GabapentinGabapentin
    68084-797GabapentinGabapentin
    68084-762GabapentinGabapentin
    0440-5562GABAPENTINGABAPENTIN
    0440-5563GABAPENTINGABAPENTIN
    68084-802GabapentinGabapentin
    68151-1028GabapentinGabapentin
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.